Upstream Processing

Nov 01, 2016
By BioPharm International Editors
Oxford Genetics has secured a GBP1 million capital from investment group Mercia Technologies to support its growth strategy in delivering new services for cancer-fighting gene-therapy technologies.
Nov 01, 2016
BioPharm International
To investigate the best culture conditions, the authors used response surface methodology via Box-Behnken design.
Nov 01, 2016
BioPharm International
In addition to having the optimal cell line and process, it is crucial to have the optimal cell culture medium and feed to maximize performance potential.
Oct 28, 2016
BioPharm International spoke with Trevor Marshall, director of enterprise systems integration at Zenith Technologies about automating processes in upstream processing.
Oct 21, 2016
Scientists from the Fred Hutchinson Cancer Research Center have developed a semi-automated benchtop system for the manufacture of gene therapy.
Oct 21, 2016
By BioPharm International Editors
Horizon announces new bioproduction outlicense deal with an unnamed partner for a minimum value of £500,000.
Oct 15, 2016
BioPharm International
Experts discuss recent advances in cell viability testing methods in bioreactors.
Oct 15, 2016
BioPharm International
BioPharm International spoke with Selexis CEO and Chairman Igor Fisch, PhD about the latest cell-line development advances.
Oct 07, 2016
By BioPharm International Editors
WuXi AppTec’s new biomanufacturing facility is its third facility in the Philadelphia, PA Navy Yard.
Oct 04, 2016
By BioPharm International Editors
Xellia added laboratory space and personnel in Zagreb, Croatia to work on anti-infective products that combat the antimicrobial resistance problem.
native1_300x100
lorem ipsum